PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain
Psychedelics Today · Psychedelics Today, LLC
August 26, 20221h 18m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.
www.psychedelicstoday.com